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Renal Division: 
Searching lor prevention, 
solving complications 

By Sharon Stephens Murphy 
There are about 25,000 
people in the United States on 
dialysis. The cost for dialysis 
is estimated at $350 million 
and the cost of transplanta­
tion is $20-25 thousand per 
patient. 
In 1969 a Wall Street Journal article 
reported, "Only about 1,700 Americans 
currently receive treatment while an 
estimated 8,000 people will die this 
year for lack of it." 
The treatment referred to is hemo­
dialysis for victims of kidney disease. 
At that time nine out of ten victims 
would die because the process was un­
available to them. 
The treatment and research of this 
disease is relatively new, dating back 
to the 1940s when hemodialysis was 
used experimentally. In the 1960s it 
became more widespread although sti II 
not financially feasible for everyone. 
Since then state and federal funds 
have guaranteed treatment for those 
afflicted . 
Today, the statistics are staggering. 
There are about 25,000 people in the 
United States on dialysis. The cost for 
dialysis is estimated at $350 million 
and the cost of transplantation is $20­
25 thousand per patient. 
Saulo Klahr, M.D., director of the Di­
vision of Renal Diseases, stresses that 
the School of Medicine is involved in 
research to find ways to treat and im­
prove the quality of life in patients 
who have the disease as well as to try 
to find the causes and cures. 
"If renal disease continues at the 
rate we are seeing now," he says, "it 
is calculated that 50 to 60 out of one 
million people are going to require 
dialysis each year. In the United States 
alone, this would give us more than 
10,000 new people every year on dialysis 
programs." 
If this trend is actual, Klahr says the 
projected cost for the dialytic popula­
tion for 1980 would be $1 bill ion. 
"Because of the economic considera­
tions, in add ition to the fact that the 
renal patient on dialysis treatment 
lacks quality of life, we must work to 
prevent the further rise of kidney dis­
ease," Klahr says. "It's an economic 
as well as a human problem." 
Klahr notes a similar situation in 
the 1940s when the i ron lung was de­
veloped. "If the scientists had con­
centrated just in the development and 
manufacture of iron lungs, we never 
would have found a polio vaccine. As 
a result, thousands of people would 
now be living in iron lungs." 
One of the primary known causes of 
end-stage renal disease is glomerulo­
nephritis. "About 60 to 70 per cent of 
all the people who require dialysis are 
patients who have had this disease," 
says Phillip Hoffsten, M.D., assistant 
professor of medicine, who is studying 
glomerulonephritis. "Many times we 
know this disease exists long before 
end-stage renal failure occurs. 
"Most people are diagnosed while they 
still have sufficient kidney function to 
support a normal life," Hoffsten ex­
plains. "A person may have glomerulo­
nephritis without it causing any symp­
toms. Some people live a normal life 
for years with glomerulonephritis, while 
others have a much shorter time before 
renal insufficiency begins. With the ad­
vance warning early diagnosis provides, 
the patient can prepare for the expected 
outcome of the disease. The object of 
research in this field is to avert progres­
sion of the disease. 
"Although people have been studying 
glomerulonephritis for about 25 years 
we still know little about the disease," 
Hoffsten says. "We know it is a very 
diverse disease, with more than one 
cause and that at present, medicine 
does not know how to favorably alter 
the course of the disease." 
Usually the etiologic agent causing 
glomerulonephritis is not known. There 
have been cases in Africa in which the 
organism which produces malaria is 
the responsible antigen causing ne­
phritis. Also, some patients who have 
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had syphilis have developed antibodies 
which are known to lead to glomerulo­
nephritis. "We don 't know in a majority 
of cases what the antigen is but it is 
a good bet that in many of the cases 
it may be a virus," Klahr says. 
"While we know very little about 
vi ral induced glomerulonephritis," Klahr 
says, "there is strong evidence that 
this might be one of thE: mechanisms 
for the production of nephritis. When 
there is an antigen (in this case a 
virus) which causes the production of 
antibodies, complexes of antigens and 
antibodies are deposited in the kidneys 
and produce renal disease. Dr. Hoffsten 
is trying to understand how this hap­
pens and how we can manipulate the 
resulting renal disease with drugs." 
In his research, Hoffsten is infecting 
mice with a type of virus which causes 
glomerulonephritis to progress in a 
predictable way. He and his colleagues 
are treating and manipulating this 
progression to try to change the course 
of the disease. It was during this work 
that he found that glomerulonephritis 
is not a hyper-immune state as thought 
in the past but an immuno-deficient 
condition. 
"We have found that when we inject 
this virus into the offspring, the mother, 
who has not received the vi rus, de­
velops an innocuous infection and be­
comes immune by exposure to her 
young," Hoffsten explains. 
"Then, we take the mother's spleen 
and give her offspring those spleen 
cells which are immune. The babies 
eliminate the virus and the glomerulo­
nephritis which would normally occur, 
does not. 
"Of course, this is not yet practical 
for application to humans because it 
involves the transplantation of cells 
from one person to another. But at least 
on a conceptual basis it tells us the 
real problem with the disease is not 
hyper-immunity but rather immuno­
deficiency. 
"We are looking at the cells which 
are responsible for the immunity in 
the mother's spleen, whether it is a 
specific kind , a lack of several or a 
lack of a cooperative effort," Hoffsten 
says. 
• 
"If renal disease continues at 
the rate we are seeing now, 
it is calculated that 50 to 60 
out of one million people 
are going to require dialysis 
each year in the United States 
alone." 





"Glomerulonephritis is the 
most common cause of renal 
disease in persons younger 
than age 50." 
Phillip Hoflsten, M.D. 
rill 
"The problem with glomerulonephritis 
is very much the same problem as with 
cancer. How does a cancer in you or 
me continue to progress when normally 
our immune system should eliminate 
it? For some reason when we grow a 
cancer or in this case a virus, our im­
mune system is blinded and does not 
recognize the foreign growth. When we 
find an answer to cancer we'll have 
one for glomerulonephritis too." 
Glomerulonephritis is the most com­
mon cause of renal disease in persons 
younger than age 50. Later in the 60s, 
70s and 80s arteriosclerosis and hyper­
tension are prevalent causes for renal 
disease. 
Obstructive uropathy also can cause 
renal disease. Mabel Purkerson, M.D., 
associate professor of medicine, is con­
cerned with this problem. 
"Obstruction to urine flow at some 
liThe consequences of 
untreated obstruction are 
destruction of #c.idney tissue 
reflected by loss of renal 
function." 
Mabel Pur#c.erson, M.D. 
point in the urinary tract occurs fre­
quently," Purkerson says. "Lesions 
which obstruct the urinary tract have 
been found in about 3.8 per cent of 
post-mortem examinations. Figures ob­
tained from autopsies of uremic pa­
tients show an incidence of about 25 
per cent, including both patients in 
whom obstructive uropathy was either 
a contributory or a major factor of 
renal insufficiency." 
Purkerson says the incidence of ob­
structive uropathy in relation to other 
caUSes of renal disease increases in 
certain age groups, such as infants and 
children with congenital abnormalities 
(aberrant vessels, constricting bands) 
of the urinary tract and elderly males 
in whom prostatic hypertrophy occurs 
frequently. Stone formation in the uri­
nary tract may be a cause of obstruc­
tion in any age group. 
"The consequences of untreated ob­
struction are destruction of kidney tis­
sue reflected by loss of rena I function," 
Purkerson says. "However, obstruction 
is generally a remediable cause of kid­
ney failure which requires prompt and 
accurate diagnosis and appropriate 
therapeutic maneuvers to preserve and 
restore renal function." 
One specific area Purkerson is study­
ing is the changes in salt and water 
meta bol ism observed frequently in pa­
tients with obstruction. She and John 
Buerkert, M.D., assistant professor of 
medicine at Veterans Hospital , have 
developed and utilized animal models 
of obstructive uropathy whereby these 
changes in salt and water metabolism 
are reproduced. 
"These animal models permit the 
study of mechanisms which might ac­
count for some of the observed phe­
3 
Renal Division 
"There are many areas of 
research because there are a 
lot of patients who already 
have advanced renal disease. 
There is nothing we can do to 
solve their initial condition. 
What we want to do is solve 
some of the complications." 
Eduardo Slatopo/sky, M.D. 
nomena in patients suffering loss of 
renal function secondary to obstruc­
tion," she says. "Better insight con­
cerning the physiological changes oc­
curring with obstruction has opened 
new and important avenues in our un­
derstanding and treatment of patients 
with urinary tract obstruction." 
While some causes of renal failure 
can be corrected, for those who al­
ready have end-stage renal disease, the 
choices are few: dialysis, transplanta­
tion or death. A major area of research 
at the School of Medicine is to see 
what can be done to improve the quality 
of life for the renal patient. 
"There are many areas of research 
because there are a lot of patients who 
already have advanced renal disease," 
explains Eduardo Slatopolsky, M.D., 
professor of medicine. "There is noth­
ing we can do about solving their ini­
tial condition. What we want to do is 
solve some of the complications. Even 
though the patient can be kept alive 
with an artificial kidney the rena I dis­
ease cannot be reversed and it is neces­
sary to try and prevent some of the re­
sulting problems." 
W. Ernest Rutherford, M.D., assistant 
professor of medicine and director of 
the renal division at City Hospital, Kevin 
Martin, M.D., research fellow, Slatopol­
sky and Keith Hruska, M.D., assistant 
professor of medicine, a're involved in 
three interrelated areas. 
One of their areas of research has 
led to information and answers to the 
problem of bone disease in patients 
with renal disease who are maintained 
on hemodialysis. 
Bone disease is a concern in di­
alysed patients because calcium ab­
sorption is a very serious problem for 
those with rena I disease. "Patients with 
kidney disease do not absorb calcium 
in the gastrointestinal tract as a well 
person does," explains Slatopolsky. 
"We know that one of the reasons ca 1­
cium is lost in the stools is because of 
low concentrations of vitamin 0 in 
blood." Because vitamin 0 is first me­
ta bol ized by the I iver and then by the 
kidney, a person with renal disease is 
unable to make a metabolite of the 
vitamin. The result is inability to ab­
sorb calcium. "We are changing dif­
ferent factors in the diet, such as cal­
cium, phosphorous, magnesium and are 
adding new vitamin 0 metabolites 
which are still experimental," Slatopol­
sky says, "to try to correct the prob­
lem." 
A related complication is the re­
tention of phosphorous. This also 
causes a decrease of calcium in the 
blood in direct proportion with the re­
lease of parathyroid hormone (PTH). 
Norma lIy, 70 per cent of phosphorous 
from the diet should be excreted in 
the urine. Slatopolsky and his col­
leagues have been looking for ways to 
control phosphorous retention wh ich 
occurs in patients with renal disease. 
They also have been experimenting 
with phosphorous bi nders. 
"Phosphorous binders don't taste 
very good," Dr. Slatopolsky explains. 
"They leave an after-taste and patients 
feel nauseated and sometimes vom it. .. 
Patients don't like it and it's very dif­
ficult to convince them to take it in the 
dry form. We have been able to make 
a capsule, but found this greatly re­
duced its binding potential." 
Because the main source of the 
body's intake of phosphorous is pro­
tein, it is impractical to try to restrict 
phosphorous from a patient's diet. A 
solution was found by Robert Sparks, 
professor of chemical engineering and 
Norbert Mason, senior research a_sso­
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"The average kidney 
• 	 transplant requires two or 
three days for clearing the 
PTH build-up." 
Keith Hruska, M.D. 
ciate in chemical engineering. They de­
veloped a new binder which can bind 
phosphates a Imost exclusively in the 
gastrointestinal tract and is active even 
• as a dehydrated gel. 
Rutherford and Slatopolsky have 
tested the gel and have had bread 
sticks made with it. The bread sticks 
taste normal and have few side effects. 
Results have been excellent in patients 
who eat the bread sticks, with phos­
phorous under control in a week to ten 
days. 
With phosphorous and vitamin D 
levels controlled, the deficiency of cal­
cium can be corrected. This is a big 
step because while the calcium de­
ficiency is very small and difficult to 
measure, its total effect multiplies over 
the yea rs a person may have kidney 
disease. "If you realize a renal patient 
may have the disease for 20 years and 
you multiply that small amount even 
for a period of three years, you are 
ta Iki ng a bout a very la rge a mount of 
lost calcium," explains Slatopolsky. 
As the calcium in the blood de­
creases, the concentration of calcium 
drops and th is stimulates the para­
thyroid glands and another complica­
tion develops. Parathyroid hormone 
(PTH) is released to maintain calcium 
homeostasis. It stimulates the osteo­
clasts which mobilize calcium from the 
bone and put it back into the blood. 
"This is very good for the blood, but 
is detri menta I for the bones. And over 
a period of time your bones deca Icify 
and become very fragile and break 
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"One of the major problems 
with people on dialysis is that 
they have accelerated 
vascular disease." 
Herschel Harter, M.D. 
easily," Slatopolsky explains. 
Keith Hruska is working on a related 
problem involving how the body handles 
PTH . Hruska found that the patient 
with renal disease has a high level of 
PTH in the blood not only because of 
increased production but because of 
decreased destruction. 
He found that while the kidney and 
liver are both responsible for creating 
fragments of the 1-84 amino acid chain 
of PTH, the liver only has an uptake 
mechanism for the intact hormone. 
Since the kidney handles both the in­
tact hormone and the N-terminal and 
C-terminal fragments, it is the im­
portant organ in the destruction of 
PTH. As a result the dialyzed patient 
maintains a high level of PTH. 
Hruska is also evaluating the handling 
of PTH following a transplant. "Renal 
patients have high levels of PTH but in 
most cases after a transplant the new 
kidney is able to clear the buildup of 
PTH. Levels then remain normal," he 
says. 
Hruska and his associates, Kevin 
Martin and Jeffrey Freitag, M.D., re­
sea rch fellow, recently have found that 
the average kidney transplant requires 
two to three days for clearing the PTH 
buildup. "We're also studying why some 
patients continue to have high PTH 
levels after transplant surgery. 
"In another study we're looking at 
the effect of calcium and magnesium 
on PTH action. We know levels of cal­
cium will determine PTH release," 
Hruska explains, "but we think calcium 
may also playa role in the actions and 
degradation of PTH." 
A method to measure PTH in the 
blood developed by Slatopolsky brought 
world fame to both the Division and III 
Slatopolsky. He immunized a rooster 
with PTH about eight years ago and it 
developed a very sensitive antibody 
which enabled the measuring of PTH in 
picograms. Although the rooster is dead 
now, it left behind enough antibody to 
supply the Division for a long time. 
While the rooster was alive, the renal 
division supplied laboratories allover 
the world with the valuable antibody. 
Also working on complications of 
renal disease is Herschel Harter, M.D., 
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assistant professor of medicine and 
medical director of the Chromalloy 
American Kidney Center. 
"One of the major problems with peo­
ple on dialysis is that they have accel­
erated vascular disease," Harter says. 
"Thei r atherosclerotic vascu lar disease 
accelerates at a rate faster than a d ia­
betic. If patients are to survive for pro­
longed periods of time, we must find 
the cause for this metabolic condition." 
More than 80 per cent of the patients • 
maintained on hemodialysis have dia­
betic tendencies, Harter says. To evalu­
ate the etiologies of this diabetic state, 
Harter in conjunction with Irene Karl, 
Ph.D., of the Division of Metabolism, 
has been using the epitrochlaris muscle 
of rats. Karl and David Kipnis, M.D., head 
of the Department of Medicine, have 
studied this muscle in normal and dia­
betic mice. They found that in diabetic 
rats there is an accelerated rate of 
amino acid release. This protein break­
down is not necessarily related to the 
glucose that is being taken up by the 
muscle. 
Harter and Karl used uremic rat mod­
els, and fed them low, medium and high 
protein diets. After ten days on the re­
spective diets the muscles were re­
IAI 
• 
moved and incubated for one or three 
hours to determine their metabolic 
function. "We found that the uremic 
muscle also had an increased release 
of amino acids similar to the diabetic 
muscle, although less severe," Harter 
says. "However, while muscles from 
diabetic animals have a decreased glu­
cose uptake, the muscles from uremic 
animals have an increased uptake. 
There are several possibilities for this 
finding, which we are currently evalu­
ating. 
• 
"Our object was to improve the met­
abolic function of the muscle. We 
found that when we fed the rats a low 
protein diet the muscle was more nor­
mal. On the other hand, the muscles 
from animals fed a high protein diet 
were very abnormal. Thus it appears 
that diet alone may affect these param­
eters. It also appears that increased 
glucose uptake and accelerated amino 
acid release may not be related to the 
same metabolic defect. There may be 
different metabolic aberrations affect­
ing each of the observed abnormali­
ties." 
Harter and his colleagues are study­
ing several different aspects of the ap­
parent diabetic tendencies of dialyzed 
patients by utilizing the rat model, al­
tering both diet and hormonal imbal­
ances and thus hoping to correct the 
defects. "Once we correct the diabetic 
state we can expect to protect the pa­
tient from vascular disease for a longer 
period of time," Harter says. 
Another complication affecting renal 
patients is an increased incidence of 
gastrointestinal disease. "It used to be 
'thought that a high percentage of 
dialyzed patients had ulcers," Harter 
says. "To examine this possibility we 
evaluated 100 patients using gastroin­
testinal X-rays, endoscopy and biopsy 
of the stomach and duodenum in con­
junction with David Margolis of the 
Department of Gastroenterology. We 
found a very high incidence of gastritis. 
Approximately 40 per cent of our pa­
tients, most of whom were asympto­
matic, had some degree of gastritis and 
that was confirmed by biopsies," he 
says. "No ulcers were documented. We 
took the most severe cases and treated 
them with a calcium carbonate prepara­
tion. 
Fifty per cent of the patients im­
proved. Thus it appears that gastritis 
and duodenitis is an extremely frequent 
complication of uremia which may be 
benefited by conventional medical man­
agement. We plan to study transplanted 
patients next." 
Another current study is underway in 
which the researchers are studying 
hormones in chronically dialyzed pa­
tients. "No studies have been well per­
formed on the responses of epinephrine 
and norepinephrine in chronically dia­
lyzed patients," Harter says. "These 
two hormones assist in the control of 
your blood pressure. We will study the 
clearance of norepinephrine by the ar­
tificial kidney in non hypertensive and 
hypertensive dialysis patients. We will 
aIso document thei r respective re­
sponses to position, med ications and 
known stimuli of norepinephrine re­
lease. We also plan to evaluate the re­
sponses to medications and stimuli in 
patients with severe renal disease who 
are not yet on dialysis." 
This, as well as other research in the 
Renal Division, is designed to improve 
the qua I ity of I ife for the patient with 
severe renal disease. Harter and his 
associates recently had the opportunity 
to evaluate a new device which, in the 
near future, may greatly improve the 
quality of dialysis and mobility of the 
rena I pati ents. 
Called the Wearable Artificial Kidney 
(WAK), the device was developed by Dr. 
Willem Kolph, of the University of 
Utah, who was also the first person to 
develop dialysis. With the assistance of 
Carol Weerts, coordinator of the dialy­
sis unit. Harter evaluated the WAK and 
made recommendations for improve­
ments. 
"The WAK is compact, lightweight 
and wearable. However, the machine is 
30 per cent less efficient than a regular 
dialysis machine and still must use a 
dialysate bath, making it cumbersome. 
Newer sorbents will improve its effi­
cacy." 
One of the advantages of the ma­
chine is that a person with an office 
job could dialyze at work with the port­
able unit, leaving more free time for 
the patient and his family. The other 
advantage is that a renal patient could 
travel with much less difficulty using 
the portable unit. 
"We are going to recommend some 
improvements," Harter says, "and if 
these things can be done, I think it will 
be a very good product." 
While research, both clinical and 
basic, is a major responsibility of the 
Division, it isn't the only one. It also is 
involved in teaching and patient care. 
Postdoctoral fellows are trained by 
the Division and 24 senior medical stu­
dents each year rotate through the Di­
vision. 
The Division also operates and staffs 
the W.U. Chromalloy Kidney Center 
which includes the six-bed Kuhn-Pelton 
unit. Patients with end-stage disease 
come here for treatment and dialysis, 
or for transplantation. Renal housestaff 
are responsible for hospital patients with 





"The goals of renal disease 
research are to prevent future 
generations from the threat 
of renal disease and to 
improve the quality of life for 
those who have no other 
choice than dialysis." 
Saulo Klahr, M.D. 
specialists serve as consultants to 
other physicians. 
Renal disease has many facets and 
most researchers agree that the com­
plete cure for it is many years away. 
As in most research, one of the major 
factors is adequate funding. Although 
the cost for dialytic population will 
cost $1 billion in a few years, renal re­
search still isn't a priority. 
"In the past fifteen years it has come 
a long way," Klahr says. "We used to 
be concerned on Iy with treati ng end­
stage renal disease. Efforts began in 
1960 to develop better and more effec­
tive ways of dialysis and transplanta­
tion. In the '60s, great strides were 
made in transplantation, but there has 
been little change in this decade. 
"The emphasis now," Klahr says, "is 
on the prevention of the disease, as 
well as solutions to some of the com­
plications which weren't evident before. 
The goals of renal disease research are 
to prevent future generations from the 
threat of renal disease and to improve 
the qua I ity of I ife for those who have 
no other choice than dialysis." 
The regular dialysis machine (above) 
compared to the recently developed 
Wearable Artificial Kidney WAK (below). 
While the WAK is 30 per cent less effi­











By Glenda King Rosenthal 
Approximately 10 per cent of the 
American population, including chil­
dren and adults, is affected by it. Of all 
the chronic illnesses, it is the number 
one cause of absenteeism in schools. 
Many millions of dollars in loss of 
manpower are caused by it every year. 
At Washington University's own Med­
ical Care Group, more than four per 
cent of the patients are treated for it. 
The problem may not be fatal , but al­
lergic disease can be a debilitating, 
confining illness, and also can be fi­
nancially important, when viewed over 
a lifetime. 
Timothy J. Sullivan, M.D., assistant 
professor of medicine and director of 
the Adult Allergy Clinic at the School 
of Medicine, says, "A little mathemat­
ics makes the problem obvious. There 
are some 220 million people in the 
United States and at least 10 per cent 
of them have an active allergic dis­
ease. The problem is there are fewer 
than 2,000 allergists in this country to 
treat illnesses which affect more than 
two million people. That's a rather 
alarming ratio." 
Fewer than half the medical schools 
in this country have someone on the 
faculty who spend their full-time inves­
tigating and caring for patients with al­
lergic diseases. "Consequently," Sulli­
van says, "a large number of physi­
cians graduate from medical school 
with no more than a cursory knowledge 
of the immune system and diseases re­
sulting from immune inflammation. 
" I must admit I was brought up on 
rather traditiona I grounds med ica Ily. I 
was educated in a medical school 
which didn't have anyone on the facul­
ty who treated allergic or immune dis­
eases. We used hospital ized patients 
almost exclusively as our examples of 
important illnesses," Sullivan says. 
"The allergic diseases, with the excep-
Those Dlise..abl~ alle..gies: 
nelV inle..esl in a common illness 
tions of very severe asthma, shock re­
actions or anaphylaxis, simply aren 't 
seen in the hospital. It's rare that the 
allergy patient being treated for his ill­
ness ever needs hospitalization." 
Sullivan says most medical stu­
dents are educated to bel ieve that if 
an illness isn't potentially fatal, it's a 
trivial one. If it's chronic and mild, as 
most allergic diseases are, it is con­
sidered to be vastly less important 
than an acute, disruptive illness of 
short duration. 
"I think because of these rather 
practica I factors, medica I students, 
myself included, simply have not been 
made aware of how prevalent these ill­
nesses are and how economically im­
portant they are if nothing else." 
Rheumatologists have to take care 
of some immune illnesses, Sullivan 
says, because a high proportion of 
rheumatic diseases are caused by im­
mune mechanisms. "There is an over­
lap. But, nevertheless, rheumatologists 
really have little interest in the large 
subset of immune illnesses which 
manifest themselves as allergies, such 
as asthma, hayfever, hives or anaphy­
laxis. 
" Unfortunately, this aspect of medi­
cine really doesn't generate much in­
terest in medical schools," he says, "It 
usually isn't until a physician gets out 
into practice that he is confronted with 
the need to evaluate and treat allergic 
illnesses. Naturally, it's hard to get ex­
cited about an illness you have never 
seen. 
"As a student, asthma was some­
thing you thought you could quickly 
come to grips with by opening a book 
and reading about the proper treat­
ment," Sullivan says. "I didn't regard 
hayfever or urticaria as significant ill­
nesses while I was in medical school. 
It's not like bleeding from an ulcer. But 
when we look at it on a larger scale, 
spread out over a lifetime, it's deserv­
i ng of some attention. But it is that 
kind of thinking, which I certainly 
typified, that's given us the situation 
which exists today. We have too few 
specialists for too many patients, with 
too little understanding of the pro­
cesses involved." 
The development of approaches to 
the treatment of allergies has almost 
exclusively been dependent upon previ­
ous trial and error, because there was 
virtually no understanding of why a 
treatment was working. A prime exam­
ple is the use of allergen injections to 
desensitize allergy patients. As early 
as 1910 physicians had empirically dis­
covered a way of giving injections of 
allergens to reduce the severity of al­
lergies. 
"In the late 1800's, German physi­
cians began to make anti-sera against 
everything they could isolate," Sulli­
van says. "The first large success was 
in the treatment of diphtheria. Horse 
anti-serum was developed against the 
diphtheria toxin. It could prevent the 
appearance of lethal aspects of the dis­




way. Consequently, a lot of enthusiasm 
was generated for developing anti-sera 
against practically everything." 
However, it soon became clear that 
injecting horse serum into a person 
might cure the illness, but a wide va­
riety of new problems would develop. 
"Soon people became allergic to horse 
serum," Sullivan says. "An attempt was 
then made to immunize people them­
selves, a much more efficient ap­
proach. It was that kind of thinking­
either giving an immune serum or 
causing patients to make their own­
which prompted physicians in the late 
1800's to believe they could prevent 
virtually any illness through immuniza­
tion." 
In this milieu physicians began in­
jecting extracts of pollens, mold 
spores, dust and other materials into 
allergic people in an attempt to im­
munize and thereby protect them. "We 
now know the improvement which oc­
curred had little to do with immunizing 
a patient against pollen," Sullivan 
says. "The mechanism by which it act­
ed was quite different from the anti­
body production physicians intended 
to activate. Yet, the upshot was that it 
worked. Because it didn't work for all 
tI people, however, there was an incen­
tive to keep looki ng." 
A variety of medications for the 
treatment of a Ilergies were subse­
• 	 quently discovered, again by trial and 
error. German physicians extracted 
adrenal glands and found that in them 
was a substance which had several 
striking pharmacologic properties. 
"They called it adrenalin," Sullivan 
says. "It was quickly found that adren­
alin could reverse many types of al­
lergic reactions. By the turn of the cen­
tury, physicians were administering 
adrenalin to people with asthma and 
a variety of other allergic reactions. 
Again, the mechanism was not under­
stood, but it didn't make a lot of dif­
ference at a time when no other drugs 
were available. It worked nicely." 
Theophylline is another example of 
a chance finding for the treatment of 
asthma. "To this day I am unable to 
determine why physicians first tried 
Mast cells: where histamine is pro­
duced and stored. 
theophyll ine for asthma treatment," 
Sullivan says. "It was one of a family 
of d rugs isolated from tea and coffee 
and then synthesized by the chemists; 
it was simply tried and it worked. 
"The upshot of this is the major 
drugs we use to treat allergic diseases 
were developed empirically. Injection, 
adrenalin and theophylline therapy 
were well underway by the mid-1930's. 
All of this was accompl ished without 
the sl ightest idea-although plenty of 
theories existed-{)f how it worked." 
According to Sullivan, the next major 
add ition to the treatment of allergic 
diseases came with the development 
of antihistamines around the time of 
World War II. Histamine was recog­
nized as an important mediator of al­
lergy as early as 1910, and in 1937 
French chemists succeeded in design­
ing drugs to block histamine actions. 
"An understanding of one aspect of 
the problem led to a specific, effective 
treatment," Sullivan says. "Our incom­
plete understanding of other funda­
mental processes in allergy has severe­
ly limited the development of more 
specific cures. Steroid hormones intro­
duced in the 1950's and now cromolyn 
sodium are again being applied to al­
lergic diseases with some success." 
Sullivan feels this empirically ar­
rived at treatment works fairly well in 
the management of most allergic dis­
eases. "However," he says, "there are 
some treatment failures, many times 
despite expensive, long, drawn-out 
treatment. So, from the poi nt of view 
of just treatment alone, we're in a 
quandary. We have some effective med­
ications, but we only pa rtia Ily under­
stand how they work. I view this as a 
rather large, significant problem in ap­
proaching the remaining therapeutic 
impasses. 
"We can handle most of our allergy 
patients but there are a good number 
of patients who are still refractory and 
are only partially helped by injection 
therapy or desensitization. Ou r empi r­
ically arrived at tools have carried us 
a long way, but we clearly need delib­
erately developed medications and in­
terventions." 
According to Sullivan, the National 
Institutes of Health are trying to en­
courage and support the development 
of academic people who study, inves­
tigate, and teach the care of immune 
diseases. In conjunction with this idea, 
Sullivan is the recent recipient of an 
Allergic Diseases Academic Award . 
"The NIH and the Department of 
HEW have begun to put a greater em­
phasis on this very neglected area in 
clinical medicine," Sullivan says. "One 
of the devices they're using to encour­
age the clinical investigation and clin­
ical teaching of immune diseases is to 
specifica Ily allocate financia I support 
for the development of academic aller­
gy people." 
Sullivan feels there is definitely an 
educational gap in the study of allergic 
diseases. "The award should bridge 
several gaps, primarily that of develop­
ing investigators and educators," he 
says. "That's really the stated purpose, 
but there is an even more important 
one. That is to provide each institution 
with an academician and educator in 
allergic diseases. What's happening on 
an overall scale is we're attempting to 
get medical educators and investi­
gators in places where they can ac­
quaint medical students with the prop­
er evaluation and care of patients with 
allergic diseases. We also want them 
to know enough to be able to recogn ize 
when the patient needs help from a 
specialist, even though the majority of 
these patients can be cared for by any 
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physician with a basic understanding 
of the principles involved." 
There has been an overwhelming in­
crease in the understanding of the im­
mune system over the past fifteen 
years. According to Sullivan, there is 
a great deal now known about the fun­
damental mechanisms by which im­
mune diseases occur, and specifically 
a great deal is being learned about the 
allergic diseases. This opportunity to 
apply rapidly accumulating basic infor­
mation to clinical problems is another 
important reason why the NIH is now 
encouragi ng investigators to devote 
their clinical and research attention to 
the immune system. 
Another reason is the new, effective, 
but potentially dangerous medications 
used for some patients. "Use of many 
of these drugs requires a great deal of 
familiarity which most physicians don't 
as yet have," Sullivan says. 
A unique knowledge of immune ill­
ness is also necessary in effective in­
jection therapy. Sullivan feels this 
has to be regarded as potentially lethal 
intervention. "We're giving the patients 
substances to which they are extremely 
sensitive, and if it isn't done properly, 
it could prove fatal. The improper use 
of these materials killed a child this 
year in East St. Louis. It is not a casual 
undertaking," he says. 
The NIH is also encouraging a 
skilled knowledge of injection therapy. 
This type of therapy can be expensive 
in time, as well as money. "Some al­
lergy patients require weekly or bi­
weekly injections for a year and then 
monthly injections for another couple 
of years," Sullivan says. "That's the 
only way of intervening in an allergic 
illness when the pharmacologic agents 
we currently use fail." 
The cost of this therapy precludes a 
lot of people from eagerly seeking care 
for allergy problems. Even though it's 
spread out over a long period of time, 
Sullivan says that in this community 
an evaluation can cost anywhere from 
$125-$300 depending on the nature of 
the illness and how many X-rays are 
necessary. "This cost isn't too different 
from an internist's work-up on some­
one with liver or kidney disease. The 
difference is it is not likely to be a fa­
tal illness. It is an avoidable expense." 
People are more likely to seek help 
for their children than they are for 
themselves. "Asthma in children is 
much easier to treat when the disease 
is of recent onset. But the point is, a 
lot of people feel obstructed from 
seeking care for an allergic disease be­
cause they can live with it and have 
other pressing demands on their re­
sources." 
Sullivan hopes the recognized need 
for specialized allergy care will influ­
ence insurance companies to pay for 
outpatient treatment. "More and more 
insurance companies are willing to pay 
for outpatient ca reo There wi II be more 
funding available for the general phy­
sician to take care of allergy problems, 
if they know how. There also will be 
more people seeking care on a private 
basis from allergy specialists." 
Sullivan hopes that through his NIH­
sponsored research a better under­
standing of the immune system will de­
velop, along with a more rapid, effec­
tive and efficient way of clinically 
treating allergy patients. 
"We now know, for example, that a 
unique IgE antibody is responsible for 
a lIergic reactions," he says. "This anti­
body appeared late in the development 
of animals, and it's found only in mam­
mals. The important point is this just 
isn't a residual part of the immune sys­
tem. It's something that deliberately 
evolved, and in the past two years it's 
become clear why." 
According to Sullivan, the IgE anti­
body appears to be a protective device 
against parasites. As a general rule, 
people in tropical countries don't have 
hayfever or asthma, but they do have 
pa rasites. 
"One British study showed that chil­
dren coming from tropical countries 
to Britain had virtually no asthma or 
hayfever," Sullivan says. "But within 
five years of their arrival, they had 
the same percentage of hayfever and 
asthma as the British children." 
There are many reasons why that 
could be, but the prevailing attitude, 
according to Sullivan, is that their im­
mune system, which was previously in­
volved in the protection against para­
sitic infection, became idle. "Their im­
mune system began to focus on en­
vironmental factors it had no business 
focusing on. 
"It's believed that the more indus­
trialized we become, the more likely 
our immune system will attack environ­
mental invaders such as dust, pollens, 
mold spores and animal danders. So, 
the allergic illnesses appear to be a 
spectrum of illnesses that are in part 
a direct result of improving our lives," 
Sullivan says. 
Sullivan became interested in exact­
ly what happens during an a Ilergic re­
action, because he felt a thorough un­
derstanding would permit researchers 
to modulate the reaction at will. "The 
specificity of the allergic reaction 
comes from the production of these 
IgE antibodies, which are ordinarily 
produced when we're invaded by para­
sites. This antibody doesn't circulate 
in the blood and attack antigens the 
way other antibodies do. It does circu­
late, but in very small quantities. On 
the other hand, it becomes bound to 
tissue cells which are called mast 
cells." 
The mast cells are virtually the only 
place in the body where histamine is 
produced and stored. "Let's take the 
example of people allergic to ragweed 
pollen. When they breathe it in, pollen 
hits their eyes, nose, airways and skin 
and pollen proteins begin to diffUse 




Timothy J. SuI/ivan, MD., hopes to gain new insights into the workings of the 
immune system through laboratory research. 
"The person who is allergic to these 
substances has already made specific 
IgE antibodies after previous exposures 
and has coated the surface of the mast 
cells. When the ragweed proteins en­
counter IgE on the mast cells, a reac­
tion occurs which activates the mast 
cell interior," Sullivan says. "This 
causes the cell to release many kinds 
of molecules, histamine being the one 
that is best understood." 
According to Sullivan, there are 
enormous quantities of histamine in 
these cells. "There isn't a tissue in the 
body, except perhaps the brain, that 
normally isn't partially regulated by the 
mast cells in the tissues. Th is biolog­
ical concept developed in very primi­
tive animals. The biologic idea of mak­
ing the secretion severe and specific 
enough to stop invading parasites came 
later. 
"The crux of our stUdies on mast 
cells," Sullivan says, "is that by study­
ing the isolated cell we hope to be able 
to ferret out which of the pharmacolog­
ic actions that we know to occur in 
complex tissues can be attributed to 
effects on the cell and which are due 
to alterations in environment. Our ob­
jective is simple: the more perfect reg­
ulation of mast cell function in the al­
lergic situation." 
Sullivan hopes that in the future this 
dimension of the immune response will 
be effectively controlled. Until recently, 
drugs to treat the allergic diseases 
have been accidentally discovered. 
"We're just beginning to systematically 
work out the mechanisms of actions of 
the drugs which are currently used. We 
have to understand the mast cell func­
tion to pharmacologically regulate that 
function when the diseases are appar­
ent. It's been impossible so far to pre­
vent the formation of IgE antibodies." 
Attempts have been made to under­
stand what portion of the IGE molecule 
binds to the surface of the mast cell. 
"As soon as we understand that, we'll 
attempt to manufacture molecules 
which resemble portions of the IgE 
molecule. This should in turn prevent 
binding to the mast cell," Sullivan 
says. "If we can do that, we can block 
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all of the IgE mediated events because 
it has to be attached to the surface of 
the cell to deliver its signals." 
Current injection therapy apparently 
doesn't significantly affect the forma­
tion of IgE molecules, even though the 
patient might be markedly better. Ac­
cording to Sullivan, it appears that the 
mechanism by which these injections 
work is a combination of many things. 
"The major factor seems to be in pre­
venting the mast cells from producing 
these abrupt secretions which cause 
symptoms. The body can cope with 
small amounts of these mediator mole­
cules. It's the abrupt, explosive release 
of histamine that causes a clinically 
apparent allergic reaction, such as an 
allergic reaction to penicillin . 
" For example, if you were to hold in 
your hand the amount of ragweed pol ­
len that hits you each year, you could 
barely see it," Sullivan says. "Yet that 
tiny amount of pollen provokes intense 
symptoms." 
However, over a period of six to nine 
months, a patient's tolerance can be 
built up to the point of desensitization. 
"We can markedly change the patient 's 
degree of sensitivity," Sullivan says. 
"The question is, have we reduced 
their sensitivity to a level at which 
they don't clinically react. We can 
build up the degree of tolerance in 
everybody; we can reduce the clinical 
symptoms in 8 out of 10 people." 
The ideal would be to develop a level 
of tolerance in the allergy patient so 
their clinical symptoms would be non­
existent. Or, if the symptoms were 
there, they could be easily suppressed . 
"Currently it takes a long time for de­
sensitization therapy," Sullivan ex­
plains, "and there are those 15 out of 
100 patients who don 't respond. This 
type of therapy isn't a cure; it is a neg­
ative modulation which then makes the 
drugs more satisfactory. We're now in­
vestigating why the cell turns off when 
it is gradually presented with increas­
ing quantities of an allergenic sub­
stance ." 
Sullivan hopes that by biochemically 
understanding how a cell is activated, 
it will permit researchers to ask how 
the cell becomes deactivated. "These 
processes cannot be separated or 
solved independent of each other. We 
are now able to investigate how the 
gradual presentation of antigen turns 
the cell off. Hopefully by understand­
ing that process we can come to grips 
with a more rapid , effective and effi­
cient way of dealing with people." 
At the present time, none of the cl in­
ically important allergic diseases can 
routinely be cured . Most can be easily 
suppressed with avoidance measures 
or medications which don't make peo­
ple ill. However, Sullivan points out 
there is still that 1 in 100 patients who 
doesn't obtain adequate relief from any 
of the current methods. 
Sullivan emphasizes that one gener­
ally measures research in terms of 
years, not weeks or even months. "We 
are trying to follow a systematic line 
of investigation. The price one pays for 
that," he says, "is research progress 
appears relatively slow, even though it 
is definite and thorough." 
In the next five years, Sullivan hopes 
to have a fairly good understanding of 
the major control mechanisms which 
regulate mast cell function. "Through 
our research we may generate the de­
liberate development of a whole new 
family of medications, as opposed to 
the chance findings we've had in the 
past. What's certain is that we'll know 
quite a bit more about how the mast 
cells are regulated, and in turn how to 
purposely regulate them." 
Su II ivan became interested in study­
ing the immune system while on a tour 
of duty with the Special Forces in 
Vietnam. "I realized that many tropical 
and parasitic illnesses are a result of 
immune attacks on infectious orga­
nisms and / or the failure of protective 
immunity. I became interested in the 
immune system by living among people 
with a spectrum of illnesses I had nev­
er seen before. One cou Id see the de­
structive and the protective aspects of 
the immune system. We usually don't 
see the immune system in such obvi­
ous activity. In a tropical country 
where sanitation is poor, one constant· 
Iy sees people battling against environ· 
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menta I problems and infectious pro­
cesses. One quickly realizes how im­
portant immunization is when you see 
these probiems in action. The immune 
system became very real to me, and 
this only emphasized how little we un­
derstand it." 
Sullivan found that a disease such 
as malaria is a satisfying one to treat 
because the patient feels so much bet­
ter in a short time. "Because I was in 
the same location for thirteen months, 
I often treated the same patients for 
ma la ria fou r or five ti meso It's extreme­
ly satisfyi ng to take care of people, but 
one has to balance long-range gratifica­
tion against immediate gratification . 
That's the difference between treating 
a disease and solving it." 
Sullivan feels he has to balance 
what he thinks his effectiveness can be 
as an educator and investigator against 
a possible role as a full-time clinician . 
"I hope I can teach enough about my 
chosen area to developing physicians 
so they can go out, amplify that knowl­
edge, and apply it. Secondly, I hope to 
be lucky enough and smart enough to 
improve the way immune diseases are 
treated. I find it extremely rewarding 
to be tackling problems, solving some I 
of them, and participating in the evolu­
tion of medical knowledge. I 
"Very seldom will someone have a 
II 
dramatic breakthrough in the labora­
tory that's going to help millions of 
people. One can't be so grandiose as ·1 
to expect that will happen," he says. Ii 
"But laboratory research on the im­
mune system can add a great deal clin­
ically. We now know so little about the 
human immune system; there are many 
gains to be made in the field. I hope to 
be able to translate some of these lab­
oratory phenomena into clinical 
changes. It's my hope that I'm going to 
be effective enough as an investigator 
and educator that my time here will 
have considerably more impact than 
what I might have accompl ished treat­
ing patients with our current insights." 
Harvest time is particularly difficult for 
the allergy sufferer. 
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War on food additives 
continues 
By Linda Nielsen Weller 
Each year food processors add more 
than 200,000 tons of monosodium glu­
tamate (MSG) to foods in largely un­
regulated amounts. Yet, MSG is known 
to have toxic effects on experi menta I 
animals, especially immature animals. 
In light of this, a scientific advisory 
committee recommended in November 
that MSG, a long with hyd rolyzed vege­
table protein (HVP), be banned by the 
FDA in infant and junior foods. 
Strongly supporting this measure is 
John W. Olney, M.D., associate profes­
sor of psychiatry and neuropathology, 
who has supported a ban since 1969. 
His resea rch has shown that MSG 
causes brain damage when adminis­
tered by mouth to young animals. 
The Advisory Committee's recom­
mendation that MSG and HVP be 
banned received little notice. For one 
reason, the additive HVP is not well­
known and second Iy, most people be­
lieve MSG was taken out of baby foods 
years ago. 
Olney says the latter is a miscon­
ception. "MSG really was not taken out 
of infant and junior foods and an of­
ficial ban is the only appropriate way 
to deal with the problem." 
Olney reported new findings in No­
vember at the annual meeting of the 
Society for Neurosciences in Toronto. 
Theodore J. Cicero, Ph .D., associate 
professor of psychiatry and neurobiol­
ogy, also attended. They said even 
when MSG is administered to animals 
in doses lower than those required to 
cause bra in damage, it resu Ited in ele­
vated blood levels of two hormones. 
Testosterone, the male sex hormone is 
one of the hormones affected. The 
other, luteinizing hormone (LH), is a 
pituitary hormone which is transported 
in blood to the testicle where it stimu­
lates output of testosterone. 
Olney and Cicero say the basis for 
these hormonal changes is that MSG 
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is able to stimulate certain brain cells. 
It is by stimulating these cells, the re­
searchers believe, that MSG causes 
sudden changes in hormonal levels. 
"We cannot say yet whether the ef­
fects of MSG on hormonal systems will 
give further basis for questioning the 
widespread use of the additive in 
foods," Olney says. "Many more studies 
will have to be undertaken. In these 
studies it will be important to ascer­
tain further the effects of daily MSG 
intake on the immature organism. We 
suspect that even at relatively low 
doses, it might cause subtle but re­
petitive disturbances in certain hor­
monal systems which are important 
for normal growth and development." 
The November recommendation came 
from a scientific committee of the 
Federation of American Societies for 
Experimental Biology (FASEB). The 
committee was asked in 1973 to study 
MSG and HVP by the Commissioner of 
FDA who was under pressure at the 
time from the Senate Nutrition Com­
mittee. 
What do the FASEB recommenda­
tions mean to the consumer? "It is too 
early to tell," Olney says, "but the MSG 
and food industries probably will wage 
new offensives to delay or obstruct reg­
u latory action. The FDA has indicated 
they will hold formal hearings to give 
interested parties ample time to file 
complaints against the FASEB recom­
mendation . 
"It will be interesting," Olney says, 
"to see what action, if any, the FDA 
finally takes. This is a tough regulatory 
problem. The FDA is under tremendous 
pressure from the MSG and food in­
dustries to avoid placing a ban on the 
use of MSG in baby foods . Such action 
would represent official recognition 
that MSG poses a significant hazard to 
at least one large segment of the popu­
lation, the immature human." 
• 

Banning the substances in baby and 
junior foods is only one part of the pic­
ture. "Young people, including infants 
and young children, actually eat many 
foods not specifically designated as in­
fant or junior foods," Olney explains. "A 
ban on MSG in infant and junior foods 
does not actua Ily protect these young 
people from MSG intake. 
"Food processors in this country and 
around the world add thousands of 
tons of MSG to foods each year. Once 
the FDA acknowledges that MSG poses 
a hazard to young people, the only way 
this sensitive population can truly be 
protected against the hazard is to ban 
aII use of the add itive. An alternate, 
but somewhat less effective approach, 
would be to require a label warning 
that food containing MSG is hazardous 
for the young. Obviously neither ap­
proach is acceptable to the industries 
concerned," 01 ney says. 
According to Olney, baby food manu­
facturers have used MSG as a flavoring 
additive since the late 1940s. In 1969 
it was brought out in Senate Nutrition 
Hearings that infants have no taste for 
MSG. It had been added solely for the 
mothers' benefit. Later that year the 
industry, while denying that MSG 
posed a hazard to the developing brain, 
announced they would voluntarily stop 
using MSG in baby foods. 
"This move had its intended effect," 
Olney says. "The public equated it 
with an offic ia I ba nand developed a 
secure feeling that their infants and 
children were being maximally protect­
ed. The facts are, however, that MSG 
still is being added to the foods that 
infants and children eat and the FDA 
never has acknowledged that MSG is 
hazardous to infants or to anyone else. 
In his study of the effects of MSG and 
other additives on small animals, John 
W. Olney, M.D., utilizes the ultra-mi­
crotome (far left). The device cuts the 
brain tissue into minute sections. He 
then mounts the pieces of tissue on 
tiny copper grids (this page), and views 
them under a microscope in order to 




" In 1970, the FDA referred the issue 
to an industry-dominated panel of food 
specialists, Their failure to question 
the safety of MSG gave FDA the neces­
sary backing to continue listing MSG 
as 'generally regarded as safe (GRAS),''' 
explains Olney, 
" I cooperated fully with the panel," 
he says, "and I was very disappointed 
when they wrote a pro-industry report. 
I later learned that the chairman of 
the panel had direct financial ties with 
both the MSG and baby food indus­
tries, In addition, most of the other 
panel members were employed by or 
otherwise financially dependent upon 
the food industry, which paid thou­
sands of dollars in 1970 to support the 
panel's operations," 
As a witness at Senate Nutrition 
Hearings in 1972, Olney testified that 
the 1970 Advisory Panel on MSG was 
riddled with conflicts of interest. He 
noted panel members apparently had 
been chosen for their industry loyalties 
rather than scientific qualifications and 
the panel demonstrated extreme biases 
in dealing with the MSG issue, 
He says he recommended that MSG 
and all other questionable GRAS ad­
d itives be re-eva I uated by a new com­
mittee of truly qualified, independent 
and objective scientists, It was this 
committee wh ich recently unequ ivo­
cally recommended that the FDA place 
an official ban on the use of MSG in 
baby and junior foods, 
The other substance, HVP (hydrolyzed 
vegetable protein) is relatively un­
known to most consumers, HVP is a 
product of hydrolysis, a method of 
breaking down proteins into amino 
acids such as MSG, Most HVP prepara­
tions are rich in MSG and also contain 
related molecules which act in con­
cert with MSG to increase its brain 
damaging potential, Olney says, 
"Methods for preparing HVP from 
proteins vary; some methods involve 
removal of other ingredients to leave 
almost pure MSG, 
"The baby food industry began add­
ing HVP to flavor infant foods at the 
same time they agreed to stop adding 
MSG," he says, 
Olney reported his research on hy-
The powerful electron 'microscope is a key instrument in examining and photo­
graphing brain tissue under study , The device enables Olney to detect the extent 
of brain damage cells in animals that have been fed food additives, 
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drolyzed proteins two years ago in the 
"New England Journal of Medicine." 
These findings played an important 
part in the conclusion of the FASEB 
committee this month that HVP also 
should be banned from use in baby 
foods. 
"I don't know why the industry is so 
intent upon fueling consumer advocate 
fires," Olney says, "but any way you 
look it it, they only pretended to stop 
adding MSG in 1970 and, in fact, have 
been adding it all along." 
When asked how much MSG has 
been added under the HVP label, Olney 
says: "I have no idea. Confront FDA 
with this question and they refer you 
to food industry representatives who do 
not seem to know themselves. Since 
the apparent aim in using HVP is to 
get enough MSG into the food to give 
it flavor, they probably have been in­
troducing sUbstantia I concentrations of 
MSG. 
"In any event, the FASEB committee 
would not have asked the FDA to ban 
the practice if they did not consider it 
potentia Ily detri menta I to the hea Ith of 
infant and junior consumers." 
While the FDA is deciding whether 
to place a partial ban, full ban, or no 
ban on MSG and HVP, Olney and his 
research colleagues at the School of 
Medicine intend to continue exploring 
the effects of MSG and related com­
pounds on immature brain and hor­
mona I systems. 
"These compounds are of extreme 
interest to the neuroscientist," Olney 
says, "because they excite nerve cells. 
I started studying MSG back in 1967 
because of this intriguing effect on 
nerve cells, and it was largely by acci­
dent that I discovered its brain damag­
ing potential." 
In the upcoming months, FDA hear­
ings will determine what, if any, limi­
tations wi II be placed on the use of 
MSG and HVP in baby and junior foods. 
If the two sUbstances are banned from 
these foods, it is conceivable that fur­
ther restrictions might be forthcoming 
to protect children as they consume 
foods not designated specifica Ily for 
ba bies or jun iors. 
Similar to the electron microscope is the leitz microscope which Olney also utilizes 
to view and to photograph damaged brain tissue. This smaller microscope operates 






In 1970, a small group of scientists at 
the Medical School formed a com­
mittee to explore an idea they had 
which would expedite cancer research 
in the Medical Center. 
Their concept was a cancer center 
to coordinate and facilitate basic can­
cer research throughout the Medical 
Center. 
Last month, this idea was fully re­
alized with the dedication of the Cen­
tralized Facilities of the Center for 
Basic Cancer Research. 
The Cancer Center was established 
to provide a focus for research, teach­
ing and seminar programs. It is also 
responsible for defining which cancer­
related areas need additional staff and 
then recruiting the necessary people. 
The Centra I ized Faci I ities were not 
completed until last year because 
the complex specialized center had to 
be planned and constructed. 
These faci I ities, located in the Mc­
Donnell Medical Sciences Building, 
are the core of the Cancer Center and 
will provide services and supplies for 
cancer research laboratories through­
out the Medical Center. Tissue Culture 
and Virus Production Laboratories will 
produce large amounts of tissue cul­
ture media, animal cells and viruses to 
be used by investigators in their own 
la boratories. 
The Electron M icroscopy Center wi II 
provide electron microscopy photog­
raphy of viruses, cells and cell sur­
faces. 
Fewer than ten such centers exist in 
the Un ited States. A unique aspect of 
the facilities is that they will supply 
services to researchers regardless of 
depa rtmenta I lines. 
"The main advantage of having one 
faci I ity is that the basic work such as 
media preparation and production of 




is the high level of expertise which can 
be achieved by centralizing these ser­
vices. 
"Because it is a large facility which 
services many investigators, we can af­
ford to have the most advanced tech­
nology available and an outstanding 
staff," he says. 
"There's a level of expertise in the 
facility which few other laboratories 
could hope to achieve. The technology 
• 
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in large quantities and distributed to 
the researchers when and as they need 
them," explains Heschel Raskas, Ph.D., 
associate director of the center. "Th is 
saves the individua I investigators time 
and money for equipment and supplies, 
and allows them to become more in­
volved with the creative aspects of their 
research." 
Robert E. Thach, Ph.D., director of 







;1Leonard Keay, PhD. , director of the 
'! Tissue Culture and Virus Production Fa­

cility, and John Mulkie , virus and cell 

technician, examine a container of cells 
 Iwhich produce virus . 

Right: Darrel! Dobbertin, assistant di­
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rector of the Electron Microscopy Fa 

cility using the electron microscope. 
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would be impossible to duplicate," 
Thach says. "Some labs can do some 
of the things we do, but none can do 
all the things we're able to do." 
More than 30 laboratories and 100 
investigators uti I ize the services of the 
Central Facilities. 
Construction of the Center was fund­
ed by a grant of more than $733,000 
from the National Cancer Institute and 
a contribution of more than $254,000 
from Washington University. 
" The Center is a biohazard facility 
which has been built to minimize the 
dangers involved with working with 
viruses. "The facilities are built so they 
are sealed off from the rest of the 
building," Thach says. "In addition, 
careful safeguards to protect people 
and the environment are followed." 
Leonard Keay, Ph.D., director of the 
Tissue Culture and Virus Production 
Facility, says the facility has become 
well-known a I ready. "We a I ready have 
been asked by a manufacturing firm to 
evaluate some equipment which can 
produce cells on a large scale. We will 
use the mach i ne for six months. 
Chances are we will be asked to make 
similar evaluations in the future." 
Thomas Rucinsky is director of the 
Electron Microscopy Faci I ity. II 
Although construction was completed 
last year, the dedication program for­
malized the opening of the Central Fa-
ci I ities. Two guest speakers attended II 
the program. Thomas J. King, M.D., di­
rector of the Division of Cancer Re­
search Resources and Centers, Na­
tional Cancer Institute, spoke on "Basic 
Research and the National Cancer Pro­
gram." Howard M. Temin, Ph.D., Mc-
Ardle Laboratory for Cancer Research 
at the University of Wisconsin and the II 
1975 recipient of the Nobel prize in 
medicine, also spoke on "RNA Viruses 
and Cancers." 
Top: Heschel Raskas, Ph.D., associate I 

director of the center, with Howard M. 

Temin, PhD., and Thomas J. King, 

M.D., speakers at the dedication pro­
gram, and Robert E. Thach, Ph.D., di
rector of the center. 

Left: Pat Pruitt and Lavey McElroy 

prepare and label containers for cell 

media in the media preparation lab. 
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WUMS stall melDbe.. 
t..avels 25,000 miles 10 .. 
United Nations 
When an official in the Ministry of 
Education in Jakarta decides that ele­
mentary school children need to learn 
about population problems and family 
planning, he can turn to a United Na­
tions-funded clearing house in Bangkok 
to find out how other countries have 
developed such curriculums. 
If a union official in the Philippines 
decides large families of his union 
members are eroding the gains he ne­
gotiated in their pay scales, he can ask 
a U.N.-funded clearing house whether 
someone has devised a way to get this 
point across to adult workers in col­
loquial language. 
If a village doctor in rural India finds 
side effects occurring frequently after 
insertion of IUDs, he can ask a clear­
ing house in New Delhi for information. 
It not only will provide him with med­
ical advice, but also help in explaining 
the problems to the village women, 
especially to the midwives with whom 
the women come in close contact. 
These are only some of the services 
U.N.-funded clearing houses provide. 
Last autumn the U.N . Fund for Popu­
lation Activities (UNFPA), sent a five­
member mission to visit these clearing 
houses in the Pacific region. 
The American on the team was Es­
telle Brodman, Ph .D., librarian at the 
School of Medicine and professor of 
medical history. The assignment lasted 
about eight weeks, during which she 
travelled some 25,000 miles. 
The group was to determine how well 
the clearing houses were meeting the 
needs of the users in the area and 
whether other needs were developing 
which were not being met. 
One of the questions facing them 
was the necessity for national , rather 
than regional or global, clearing 
houses. This issue is especially perti­
nent in countries where English is not 
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spoken, entailing translation of all ma­
terials before any could be used. 
This is not the first time Brodman 
had worked in this geographic or sub­
ject area. In 1961-1962, she was visiting 
professor at Keio University in Tokyo. 
In 1968 she was expert consultant to 
what is now called the National Insti­
tute for Family Planning in New Delhi. 
In 1970 Brodman performed the same 
task at the Regional Office of the World 
Health Organization in New Delhi. 
Th ree yea rs later, with a group of other 
faculty from Asia and the West, she 
presented a three-week workshop in 
techniques for population documenta­
tion centers in Bangkok. In the U.S. 
she had been chairperson of a commit­
tee of the U.S. Agency for International 
Development which evaluated the work 
of the Technical Information System 
of the Carolina Population Council at 
the University of North Carolina. 
"It has been interesting to see the 
changes in attitudes of individuals and 
governments on family planning over 
the years," she says. "Birth control is 
still a term which few governments 
wish to use, however, because of its 
implications of pressure in a very per­
sonal area of life. It may even connote 
genocide in some cases." 
However, "most governments now 
have come to accept the fact that fam­
ily planning and population dynamics 
must be integrated with other subjects 
to be acceptable to their citizens. That 
is why population is now taught as part 
of many subjects in schools." Brodman 
says in some places they teach how to 
figure percentages using examples 
from population data. 
She says since most of the popula­
tion of southeast Asian countries are 
illiterate, comic books, slide-tape pre­
sentations, posters and other non-read­
able media must be utilized. For exam­
ple, the International Labor Office has 
produced a series of large blocks with 
pictures on them which can be used by 
a speaker to illustrate his talks. 
Confusion can result, though, when 
countries exchange educational materi­
als. A poster designed in southern Java 
showed men and women in native In­
donesian dress; when it was used in 
Malaysia, problems arose because the 
clothing was so different they could 
not tell the man from the woman. 
And the world-wide problem of put­
ting scientific concepts in layman's 
language is complicated if the lan­
guages are different th roughout the 
country, such as in India, where there 
are over 50 official languages. To over­
come this problem, village officials, lo­
cal school teachers and clergy are im­
portant "filtering devices." "That is 
why we tried to examine the position 
of national and local clearing houses 
in the scheme of things," Brodman 
says. 
The mission found many problems 
with local and national clearing 
houses. Countries are at varying levels 
of sophistication in the use of any 
means of scientific transfer. Even li­
braries, Brodman says, which are taken 
for granted in developed countries, are 
new experiences for some countries. 
"They don't know what such institu­
tions can do for them, how they can 
use them or how much money it would 
take to run them. But it is a matter of 
national pride in many places to say 
the country has a national clearing 
house." 
Profound changes are taking place 
in information processing, Brodman 
points out. "A global population infor­
mation network is technically possible 
today, using computers and satellites, 
but it may be too expensive and per­
haps too sophisticated for some coun­
tries to use such a system." 
Many countries, she notes, do not 
even have the back-up equipment 
needed, such as photocopiers and mi­
crofilm reading machines. 
Before departing, the group was 
briefed first at the U.N. in New York, 
then at UNESCO (United Nations Educa­
tional, Social and Cultural Organiza­
tion) in Paris and finally at the WHO 
(World Health Organization) in Geneva. 
After the trip, the group reported in 
person to the UNFPA before returning 
home to write thei r reports. 
Brodman says one of the human in­
terest aspects of the trip was her ob­
servation of changes in the area as a 
result of the transformation of many 
governments into one-party systems. 
This had occurred recently in both In­
dia and Thailand. In fact, says Brod­
man, the change in government in 
Thailand happened shortly before the 
groups were scheduled to go to Bang­
kok. There was some question at that 
time whether it would be safe for the 
mission to visit that city. 
"But everything seemed very quiet 
all the time we were there," she says. 
"There were curfews and soldiers in 
evidence everywhere, but for the most 
part the people were going about their 
regular business just as always. 
"It was i nteresti ng to see the d iffer­
ences in the various non-democracies," 
she says. "In India, for example, there II 
were large billboards and signs on all 
the buses with Mao-like injunctions, 
such as 'Talk less and work more,' or 
'Be kind to visitors.' Newspaper ads 
pledged loyalty to the programs of Mrs. 
Gandhi, and there was little criticism 
of the government in the papers," 
Brodman says. Because India had had 
monsoons and several good years for 
crops, she says most people were bet­
ter off than when she last visited the Jl 
country. 
One of the effects the non-democrat­
ic governments have on the clearing 
houses is the i nsta bi I ity of the mem­
bers of the government. "They are I' 
moved around from position to posi­
tion, often before they have ti me to 
learn the problems in that position." 
She says such officials "often make de­
cisions about clearing houses which 
might be the opposite of what their 
predecessors did. This results in wast­
ed time and energy." The problem is 
wide-spread, she says, because in Asia 
all important institutions are parts of 
the governments. II 
Of all the cities she visited, two were 
especially important-Bangkok and 
New Delhi. Each had two clearing 
houses funded by the UNFPA, and 
each had to decide what their future 
courses would be. The fifth institution 
she visited, the Press Foundation of 
Asia, was in Manila. Brodman also con­
24 
Helen Lewis-Jones (left), Program Officer for the U.N. Fund for Population Activities, consults with Estelle Brodman, PhD. 
Lewis-Jones came to St. Louis to collaborate with Brodman in compiling a final report . 
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suited with officials in Pakistan and In­
donesia. 
In Bangkok, ESCAP (Economic and 
Social Council for Asia and the Pacif­
ic) has had a clearing house since 
1971. "As the oldest and largest one," 
she says, "this clearing house has been 
asked to do a great many things, and 
unfortunately has tried to respond to 
all requests. 
"It was tremendously successful at 
the beginning, but now they have 
spread themselves too thin," she says. 
"They're either going to have to stop 
some programs or get more people and 
money to carry them on. I'm inclined 
to think that the recent UNFPA deci­
sion to put more resources into nation­
al projects and fewer into regional and 
global projects will make it difficult for 
them to get the money that is needed 
for everything." 
The other clearing house in Bangkok, 
UNESCO, has a more limited audience 
and an even more limited group of ser­
vices, she says. Because of this, the 
center can delve into problems more 
deeply. The UNESCO clearing house 
has mobile teams which visit other 
Asian countries upon invitation from 
the governments. There they work with 
the local officials on their education 
problems and collect local "fugitive" 
or hard-to-Iocate literature for sending 
back to Bangkok. 
The literature usually is items either 
mimeographed or typewritten, pub­
lished in only a few copies for local 
use, but might contain data or statis­
tics usefu I to other groups in other 
countries. Unless they are obtained 
quickly, Brodman says, it may not be 
possi ble to ever find a copy. 
In New Delhi, she says, the mission 
found two different types of clearing 
houses. One at the National Institutes 
for Family Planning and the other at 
the regional Office of the World Health 
Organization. 
Brodman says it was difficult to com­
pare because the two had very differ­
ent aims. The group felt, however, that 
the WHO had emphasized reviews of 
the literature rather than individual­
ized services. "It also serves only the 
elitist medical groups in the area, with 
no one there to translate its findings 
into language understandable to policy 
makers and communication workers." 
Almost all clearing houses publish 
newsletters, lists of new books and 
journal articles, translations and kits 
of "how to" materia Is. The centers a Iso 
distribute pUblications to people work­
ing with and researching population 
problems. 
Almost all of the clearing houses 
have networks of correspondents in 
cities throughout the region to alert 
them to important news. 
"One of the most interesting ways 
that we saw of dispersing information 
about population and family planning 
is used by the Press Foundation of 
Asia in Manila . The Foundation utilizes 
free lance newspaper reporters 
("stringers") throughout southeast Asia 
for stories on population. They collect 
the stories and furnish them to other 
newspapers, translated into local lan­
guages. 
In this way, Brodman says, the Press 
Foundation hopes to replace the over­
whelming abundance of stories in the 
papers about the "developed" world 
with articles on developing nations. 
When asked for her view of the fu­
ture of population clearing houses, she 
says, "the future course of population 
documentation centers and clearing 
houses is uncertain. 
"On the one hand, computers and 
communication by satellite offer sev­
eral possible global network roads. On 
the other hand, strengthening tradition­
al libraries and knowledge resource 
bases might be the path for the next 
decade or so. 
"Population itself, as now defined, 
may become so 'integrated' with other 
important social areas as to lose its 
singular identity. The present view," 
Brodman says, "is that population and 
family planning should be woven into 
the rest of life, rather than being con­
sidered a separate issue. It certainly is 
more effective when each aspect rei n­
forces the others." 
An example Brodman gives of this 
integration is lifestyle changes, such 
as urbanization of families without ex­
tended family groups and more women 
joining the labor force. "These 
changes, interwoven with population 
planning, are all mutually conducive 
to family planning." 
One aspect that bothered her, she 
says, is that nobody seemed to be pay­
ing enough attention to the future of 
population documentation centers and 
clearing houses, not only in Asia, but 
also internationally. .. 
"The changing definition of popula­
tion, differing emphasis on population 
matters in many countries, the rise of 
nationalism everywhere and the new 
technology of communication all tend 
to foretell a change in the position of 
population documentation centers. 
"What, for example, will be the rela­
tionship between national clearing 
houses and regional or global ones?" 
Brodman asks. "Who will take on the 
'neutral' stance of the international 
group, whereby information is provided 
to countries who do not talk to each 
other directly, if regional clearing 
houses are dismantled? And who will 
provide the personalized services in 
their own language, which are now of­
fered by national and local clearing 
houses if there are only regional and • 
i nternationa I ones? 
"Finally," Brodman says, "who wi II 
care for population, narrowly consid­
ered, if only an umbrella-type clearing 
house for social affairs in developing 
countries remains?" 
Brodman says these are the ques­
tions she would like to see addressed 
in the near future. 
Why did the UNFPA select her for 
the mission? "Well, they needed some­ I 
one who knew something about the 
area, who was a librarian, and who 
could go at the time that the mission 
was scheduled to leave. I guess I fitted I 
those requirements," she says. 
Brodman says this will probably be 
her last mission to the East, as future 
evaluations are likely to occur after her 
retirement. Her work in the transmis­
sion of scientific information will con­
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William H . Danforth, M .D., Chancel/or of Washington University, and Mrs. Danforth read over the achievements of Wa shing­
ton and St. Louis Universities Medica l Centers at the Tribute to St. Louis Medicine Dinner wi th Bernard A. Ehrenreich, execu­
tive director of the St. Louis chapter of the March of Dimes Foundation. 
WUMS Honored 
During St. Louis 
Medicine Tribute 
Oliver H. Lowry, M.D., Ph.D., profes­
sor of pharmacology and former head 
of the department, was honored for his 
contri butions to the advancement of 
medical science last month during a 
week long Tribute to St. Louis Medi­
cine. 
Goronwy O. Broun Sr., M.D., dean 
emeritus and professor of medicine at 
St. Louis University also was recog­
nized . 
The St. Louis area chapter of The 
Birth Defects' March of Dimes Founda­
tion sponsored the event to pay tribute 
to medicine in general, individual mem­
bers of the profession and Washington 
.and St. Louis Universities Medical Cen­
ters for their " tremendous accomplish­
ments in improving the public health, 
particularly in the past 50 years." 
Community leaders joined the March 
of Dimes to make the week a success. 
Broun and Lowry were recognized at a 
banquet which culminated the tribute. 
Lowry was honored for his nationa Ily 
recognized studies of the nervous sys­
tem. 
The recipient of many nationa I 
awards and a member of the National 
Academy of Science, Lowry is world 
renowned for his work in microtech­
niques as well as for other research. 
Dr. C. Rollins Hanlon, Chicago, pres­
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Etcetera 
ident of the American College of Sur­
geons was the principal speaker at the 
dinner. 
Dr. Rollins spoke on "Medicine: 
Where We Are Going; Where We Have 
Been." 
Howard M. Love, president of Na­
tiona I Steel Corp., and cha i rman of the 
St. Louis Medicine Week said, "The 
achievements of medicine in every 
area of health care has been enormous, 
particularly in the past 50 years. We 
feel that the time is long past due to 
recogn ize these contributions. 
"We want all deserving persons and 
institutions in medicine to know that 
we respect and appreciate what they 
have accomplished in furthering the 
public health and in contributing to the 
well-being of our fellow citizens through 
their scientific research, through treat­
ment and devotion to the principles of 
their profession," he said. 
The program paid particular tribute 
to the achievement of the medical 
schools of Washington and St. Louis 
Universities, local practitioners, scien­
tific researchers and members of the 
nursing and related professions. 
Names Make News 
Carl Frieden, Ph.D., professor of bio­
logical chemistry at the School of Med­
icine, has received the 1976 St. Louis 
Section American Chemical Society 
Award. 
The award is presented annua lIy for 
outstanding contributions to chemistry. 
Frieden's particular area of research 
interest involves enzyme kinetics and 
the mechanism of enzyme action. 
He is a graduate of Carleton College 
and of the University of Wisconsin, 
where he received his Ph.D. 
Eli Robins, M.D., Wallace Renard Pro­
fessor of Psychiatry, will receive the 
Paul H. Hoch award from the American 
Psychopathological Association on 
March 3. He will receive a gold medal 
and cash award at the Association's 
67th annual meeting at the Hotel 
Americana in New York City. 
Dr. Robins wi II receive the award for 
his lifetime research in the field of 
psychiatric illness, with a special em­
phasis on his clinical psychiatric re­
search, and the diagnosis, treatment 





A new time-release contraceptive 
which is injected into the cervix is be­
ing developed at the School of Medicine. 
However, un I ike other contraceptive 
inoculations, this one should not affect 
the menstrual cycle nor prevent ovula­
tion. 
David W. Keller, M.D., assistant pro­
fessor of obstetrics and gynecology, is 
researching the procedure which con­
sists of injecting microscopic capsules 
beneath the surface of the cervix. The 
micro-capsules contain time-release 
doses of progesterone. 
Progesterone, a female hormone, acts 
upon the cervical mucus, making it hos­
ti Ie to sperm penetration. 
"We're not using a synthetic prepara­
tion," Keller stresses. "A woman's body 
naturally produces progesterone. In the 
midd Ie of her cycle, protein fibers in 
the cervical mucus are optimally 
spaced for sperm passage. After ovula­
tion progesterone is produced and the 
fibers intermesh. This position change 
makes it impossible for sperm to pass 
between the fibers and into the uterus." 
Keller hopes to duplicate the natural 
progesterone production so the fibers 
will block sperm passage every day of 
the menstrual cycle. 
He estimates the injections would be 
effective for about a year. The method 
is not designed for those who might 
soon change their minds about having 
a child, Keller says. However, he will be 
studying the possibilities of reversing 
the procedure. Work on the new con­
traceptive is funded by a grant from 
Northwestern University, Evanston, III. 
Robert E. Sparks, Ph.D., professor of 
chemical engineering at Washington 
University, is assisting Keller. "Dr. 
Sparks is seeking to find a method of 
putting the hormone into the micro­
capsules so they will be time released," 
says Keller. "If they can be implanted 
once a year, it will be more convenient." 
Keller and Sparks are testing the in­
jections on cattle at the University of 
Missouri-Columbia . "We are studying in 
vitro sperm penetration," he expla ins. 
"We already can decrease sperm pene­
tration significantly. We are planning to 
test the fertility of the animals and then 
develop reasonable release rates for the 
capsules. 
"We hope to see its effectiveness in 
the next six months," Keller says. 
"We're just starting to measure the re­
lease rate of progesterone." 
The contraceptive injections are ad­
vantageous because they should not in­
terfere with the menstrual cycle. "This 
has a local effect only," Keller says. 
"There are no pain fibers in the cervix 
so it is a conven ient place to do this 
type of injection. It is relatively pain­
less." 
Keller also foresees the possibility of 
utilizing an air gun such as those used 
by dentists, thus eliminating the need 
for a needle. The capsules would be 
shot directly into the cervix, being 
propelled by compressed air within the 
gun. 
"It is not the answer to America's 
contraceptive problems, though," he 
says. "It is designed for people with 
relatively poor motivation, such as 
those who cannot remember to take a 
pill or who will not USe other devices. 
This would be an alternative to steri­
I ization, for someone who needs long­
term contraception but who does not 
want to be sterilized." 
Multiple Sclerosis 
Grant Received 
The School of Medicine has received 
a three-year grant of $104,890 from the 
National Multiple Sclerosis Society to 
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continue support of research by Rich­
ard Bunge, M.D., professor of anatomy 
and neurobiology. Patrick Wood, Ph.D., 
research instructor, will collaborate 
with Bunge in this work. 
Bunge is studying myelin-forming 
cells. In multiple sclerosis, for reasons 
not yet understood, the myelin sheath 
of the central nervous system nerve 
fibers is damaged and destroyed. 
Bunge hopes to gain a better under­
standing of how the number of my­
elin-forming cells in the central ner­
vous system is determined, how they 
are induced to form myelin sheaths, 
and to learn why the normal number of 
myelin-forming cells sometimes is not 
restored when the myelin sheath breaks 
down. In addition, he would like to bet­
ter understand why supporting cells are 
able to reform myelin sheaths in cer­
tain demyelinating conditions and not 
in others. 
This grant brings the Society's sup­





Twenty-four students at the School of 
Med ici ne were honored for scholastic 
excellence during the 1975-76 academic 
year at a December Awards Assembly. 
Awardees from the St. Louis area and 
thei r honors are: 
Michael R. Green-Carl F. and Gerty 
T. Cori Prize in Biochemistry, for 
superiority in the field; 
Peter L. Jacobson-Lange Medical 
Publications Book Award for high aca­
demic standing during the junior year; 
Thomas R. Kleyman-Lange Medical 
Publications Book Award for high aca­
demic standing during the sophomore 
year; 
Keith L. Parker-Carl F. and Gerty T: 
Cori Prize in Biochemistry for superior­
ity in the field; 
Lee S. Portnoff-Lange Medical Pub­
lications Book Award for high academic 
standing during the sophomore year; 
John J. Schier-Lange Medical Publi­
cations Book Award for high academic 
standing during the junior year; 
Kenneth N. Scissors-Ciba Book 
Award for laudable extra-curricular 
community service. 
Other students honored include: 
Kendall H. Barker, Grosse Pointe 
Farms, Mich.-Dr. Robert Carter Medical 
School Prize, for meritorious perform­
ance during the freshman year; 
George A. Chaitkin, Skokie, II I.-Carl 
F. and Gerty T. Cori Prize in Biochemis­
try for superiority in the field; 
Patrick N. Dwyer, Ruxton, Md.-Dr. 
Richard S. Brookings Medical School 
Prize for meritorious performance dur­
ing the junior year; 
Mitchell P. Fink, San Rafael, Calif.­
a Medical Alumni Scholarship Fund 
Prize for scholastic excellence; 
Erik M. Gregorie, Alexandria, Va.­
Gill Prize in Anatomy for outstanding 
anatomical work; 
Robert A. Gross, Worcester, Mass.­
Edmund V. Cowdry Prize in Histology 
for outstanding performance in micro­
scopic anatomy; 
Bruce A. Kraemer, Tulsa, Okla.­
Lange Medical Publications Book 
Award for high academic standing dur­
ing the freshman year; 
Joan K. Kreiss, Princeton, N.J.-Dr. 
Margaret G. Smith Award for outstand­
ing achievement by a female student 
during the first two years of medical 
school; 
Timothy J. Ley, Lakota, Iowa-Dr. 
Richard S. Brookings Medical School 
Prize for meritorious performance dur­
ing the sophomore year; 
Steven McGee, Portland, Ore.-Antoi­
nette Frances Dames Prize in Physiol­
ogy and Biophysics for scholastic 
superiority in the fields; 
Ross E. Morgan, Wheat Ridge, Colo.­
Dr. Robert Carter Medical School Prize 
for meritorious performance during the 
sophomore year; 
Timothy Patton, Lacey, Wash.­
Chouke Prize in Anatomy for superior 
scholarship in the field; 
Victor L. Schuster, Glenwood, lowa­
Dr. Robert Carter Medical School Prize 
for meritorious academic performance; 
James E. Schwob, Iowa City-Lange 
Medical Publications Book Award for 
high academic standing during the 
freshman year; 
Allen J. Sedman, Southfield, Mich.­
Antoinette Frances Dames Prize in 
Physiology and Biophysics for scholas­
tic superiority in the fields; 
Mark C. Udey, Ft. Atkinson, Wis.­
Dr. Richard S. Brookings Medical 
School Prize for meritorious perform­
ance during the freshman year; 
Stephen G. Young, Topeka, Kan.-Mc­
Cordock Book Prize in Pathology for 
general excellence in the field. 
Students Named 
ToAOA 
Twenty-one students at the School 
of Medicine have been elected to Alpha 
Omega Alpha by the faculty and the 
135 seniors. 
AOA is a national honorary society 
recognizing outstanding scholarship and 
leadership in medicine and related 
fields. It is considered the most pres­
tigious honor society in med ici ne. 
St. Louis area students elected to 
the society are: John W. Campbell, 
David D. Desper, Peter L. Jacobson and 
John J. Schier. 
Other students elected include: Laird 
A. Bell, Overland Park, Kans.; James T. 
Brown, Springfield, Mo.; Charles Carras­
co, Ogden, Utah; Patrick N. Dwyer, Rux­
ton, Md.; Mitchell P. Fink, San Rafael, 
Calif.; Pamela G. Freeman, Clarkston, 
Ga.; G!enn S. Gollobin, Teaneck, N.J.; 
Warner C. Greene, Mesa, Ariz.; Kay Mil­
ler, Mill Valley, Calif.; Duane L. Mitzel, 
Vallejo, Calif.; John W. Ogle, Denver, 
Colo.; Thomas E. Phillips, Manhattan, 
Kans.; 
Victor L. Schuster, GlenWOOd, la.; 
James W. Steger, Prospect, Ky.; How­
ard G. Welgus, Flushing, N.Y.; Richard 
F. Williams, Mt. Vernon, Mo.; and Scott 






Sol Londe, '27, St. Louis, is retiring 
from the practice of pediatrics. Dr. 
Londe is an associate professor of pedi­
atrics and has been on staff at W.U. 
for more than 40 years. 
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James F. Nolan, '38, Los Angeles, was 
honored at a testimonial dinner given 
by the Alumni Association of Cali­
fornia Hospital. A. N. Arnesen, '28, Hen­
ry Schwarz II, '41, Theodore A. Lynn, '38, 
Louis Hemplemann, Jr., '38, participated 
in the program. 
Irving L. Berger, '39, Cleveland, is presi­




Gordon F. Moore, '40, Alton, III., was 
honored at a dinner by the citizens of 
Alton for his outstanding contributions 
to the community. The city dedicated 
a park in his honor which will be of­
ficially called the Gordon F. Moore 
Park. 
Ewald W. Busse, '42, has been named 
the Associate Provost and Dean of Med­
ical and Allied Health Education at 
Duke University Medical Center, Dur­
ham, N.C. 
William L. Topp, '41, Seattle, was elect­
ed chief-of-staff of the Virginia Mason 
Hospital. 
Edward J. Twin, '45, Kansas City, Mo., 
is the executive director of the New 
Truman Medical Center, Primary Teach­
ing Hospital for UMKC. He also is a 
member of the Missouri State PSRO 
council. 
Robert A. Huckstep, '48, has served 12 
years on the school board of the Farm­
ington RVII school district, and for 
three years as president of the Gov­
ernor's Conference on Education. 
'50s 

Kenneth Huey, '55, Sun City, Ariz., has 
been elected chief of the medical staff 
at Boswell Memorial Hospital. 
Eugene Nagel, '59, is now professor and 
chairman of the Department of Anes­
thesiology at Johns Hopkins University. 
David L. Winter, '59, Washington, D.C., 
NASA Director for Life Sciences, was 
elected corresponding member of the 
International Astronautical Academy. 
James H. Dunlevy, Jr., '51, Fairfield, 
Iowa, has finished one year as presi­
dent of the Jefferson County Medical 
Society. He has served on the execu­
tive council of the Lutheran Church in 
America for the past seven years. 
'60s 
R. Michael Sly, '60, professor of pedi­
atrics and director of Pediatric Allergy 
and Immunology at Louisiana State 
University Medical Center, New Orleans, 
has written a book entitled Pediatric 
Allergy. 
Robert Waldman, '63, Morgantown, W.Va., 
has been named professor and chair­
man of West Virginia University's De­
partment of Medicine. 
Charlie W. Shaeffer, Jr., '64, Palm 
Springs, Calif., is the chief of cardiol­
ogy at Eisenhower Medical Center, Palm 
Desert. 
Elliott Prather Palmer, '66, recently has 
been appointed to the associate staff 
in the Department of Neurology at the 
Lahey Clinic in Boston. Dr. Palmer is 
a member of AMA and a junior mem­
ber of the American Academy of Neu­
rology. 
Ronald E. Rosenthal, '61, Nashville, was 
recently awarded an NIH grant to con­
tinue "Studies of Synovial Response to 
Acute Trauma." He also was appointed 
to the Tennessee Chapter of the Com­
mittee on Trauma of the American Col­
lege of Surgeons, and will continue as 
associate professor of orthopedics and 
rehabilitation, and associate professor 
of anatomy at Vanderbilt University. 
Morris W. Pulliam, '66, was appointed 
assistant professor of neurological 
surgery, University of Missouri and 
chief of section of neurological sur­
gery, Veterans Hospital, Columbia. 
'70s 
John D. Reinhard, '73, Chicago, was 
awarded the Norris L. Brookens Award 
from the Illinois Society of Internal 
Medicine. This award is given to the 
most outstanding resident in internal 
medicine in the state. 
J 
James Seegers, '73, received a MAP­

Reader's Digest International Fellow­

ship. Dr. Seegers is assigned to Mon­

rovia, Liberia for three months. Made 
' J 

possible by a grant from the founder 

of Reader's Digest, DeWitt Wallace, the 

program provides three-month assign­

ments to rural mission hospitals and 





Lee A. Rigg, '71, La Jolla, Calif., has 

completed residency in OB/ GYN and 











Ian M. Smith, M.D., Johnson City, Tenn., 
has been appointed professor and 
chairman, Department of Internal Med­
icine at the new medical school, East 
Tennessee State University. 
Heskel M. Haddad, M.D., is editor-in­
chief of Metabolic Ophthalmology, a 
new international journal of basic re­
search and clinical applications. The 
magazine is the official publication of 
the International Society on Metabolic 
Eye Disease. 
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Howard N. Ward, M.D., is the director 
of Medical Education, Stormont-Vail 
Hospital, Topeka, and assistant pro­
fessor of medicine at the Kansas Uni­
versity Medical Center. 
Leonard Wartofsky, M.D., Kensington, 
Md., has been appointed chief of the 
Kyle Metabolic Unit and Endocrine­
Metabolic Service of the Walter Reed 
Army Medical Center. 
J. Joseph Marr, M.D., is professor of 
medicine and microbiology and Director 
of the Division of Infectious Diseases 





Stephen M. Patz, '69, has authored an 
article entitled "One Hospital's Ap­
proach to Word Processing" which was 
published in the October issue of Med­
ical Record News. Patz is assistant ad­
ministrator at Sinai Hospital of De­
troit. 
James A. Felts, assistant professor of 
anesthesiology at Washington Univer­
sity School of Medicine, was re-elected 
Speaker of the House of Delegates of 
the American Society of Anesthesiol­
ogists at the annual meeting which was 
held in San Francisco in October. 
Washington University Medical Center Alumni 
Contributors-1 976 Student Loan Fund 
Over the years this Fund has assisted scores of Washington University medical students in meeting their expenses, especially 

those of an emergency nature. As educational costs continue to rise, the Fund assumes increasing importance. 

Grateful thanks is extended to all 1976 contributors . 

FACULTV AN 0 FORM ER Francis J. Riley CLASS OF 1933 CLASS OF 1940 Andrew S. Lanier 
HOUSE OFFICERS Bahij S. Salibi Angelo Bologna David Goldring Nicholas H. Nauert, Jr. 
Charles L. Abramson 
Elisha Atkins 
Charles L. Abramson 
Elisha Atkins 
Wagih A. Bari 
Andrew M. Brown 
Samuel Canaan 
John W. Cavo 
Robert S. Cohen 
K. C. Das 
Donald Dickler 
Ira J. Friedman 
Florentina U. Garcia 
Richard P. Gerhardstein 
Isa A. Samad 
Ernest W. Saward 
Stephen G. Sinclair 
Sterling B. Suddarth 
Francis J. Troendle 
Ed ith Trugly 
Raymond E. Yadon 
Hector leva Ilos 
CLASS OF 1927 
Theodore Fischer 
CLASS OF 1928 
Robert H. Riedel 
William F. Wenner 
Edwin R. Westbrook 
CLASS OF 1934 
James M. Baker 
Ben P. Frissell 
Ralph R. Jones 
Jean F. Rogier 
Keith S. Wilson 
CLASS OF 1935 
Carl H. Hamann 
Nathan K. Jensen 
Clark G. Porter 
Charles G. Obermeyer 
John S. Skinner 
CLASS OF 1941 
Randall Connolly 
Anne T. Goetsch 
John P. Lee 
CLASS OF 1942 
William M. Anderson 
William A. Black 
Herman T. Blumenthal 
Irving A. Kotner 
Herman Rice 
CLASS OF 1947 
Kenneth R. Dirks 
H. L. Townsend 
CLASS OF 1948. 
Lyle W. Burroughs 
Everett R. Lerwick 
Jacob Malin 
Helen A. Stokinger 
CLASS OF 1949 
Louis Kurahara 
John F. O'Brien 
Dale M. Schulz 
Percy V. Gladdy 




Albert E. Hesker 
Robert W, Huntington 
Richard E. Johnson 
Donald C. Johnston 
Stephen Kessler 
Frank H. Kidd, Jr, 
David Kipnis 
Ruth Kramer 
Morton R. Lazar 
Arnold Markowitz 
J. Guerra Medina 
William T, Newton 
William R. Oakes 
W. H. Oehlert 
CLASS OF 1929 
Pau I R. Boren 
Alexander Freshman 
Gabriel A. Rivera 
CLASS OF 1930 
Donald E. Eggleston 
Edmund H. Werling 
CLASS OF 1931 
Benjamin D. Friedman 
H. Lee Hoover 
CLASS OF 1932 
Edwin K. Chunghoon 
Edward J. Kloess 
William H. Meinberg 
Sydney S. Pearl 
George M. Powell 
CLASS OF 1936 
Merri II C. Davenport 
Edgar L. Engel 
Nathan R, Kahn 
John W. Records 
Robert H. Rutherford 
Robert T. Tidrick 
Michael S, Wepprich 
Robert A. Wise 
CLASS OF 1937 
Lloyd E. Rosenbaum 
CLASS OF 1938 
Alfred Golden 
J, Robert Mangum 
Frank J. Weber, Jr. 
CLASS OF 1939 
CLASS OF 1943M 
Edward H. DUnn 
Robert B. Pappenfort, Jr. 
Wilfred E. Wooldridge 
CLASS OF 19430 
John H. Eisenhauer 
James G. Owen 
James C. Vest 
William S. Welborn 
CLASS OF 1945 
John C. Herweg 
George L, Rider 
CLASS OF 1946 
Jack Barrow 
CLASS OF 1950 
Walter C. Adams 
Peter L. Hurst 
Robert I. Pfeffer 
Frank J. Skerbeck 
Richard L. Swarm 
Gloria W. Troendle 
William R. Vineyard 
CLASS OF 1951 
Melvin L. Faw 
Ann Hunt 
Max K, Mendenhall 
Orin J. Riddell, III. 
CLASS OF 1952 
Eric I. Anderson 
Frank W. Clippinger, Jr. 
William R. Cole 
Reynaldo Pagtakhan Arthu r Steer Mark J, Brockbank Boyd E, Hayward Mary A, Davis 
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Class Notes 
Albert T. Nambu 
Sherman O. Schachter 
Ronald L. Scott 
CLASS OF 1953 
William F. Capps, Jr. 
Paul W. Herron 
John R. Lichtwardt 
Malcolm H. McGavran 
Dona ld C. Meredith 
Donald Rin sley 
CLASS OF 1955 
William C. Barrette 
Waller W. Cooper 
Richard R. Dewey 
Robert C. 	 Drews 
L. Bruce Ell is 
Selna L. Kaplan 
Glendall L. King 
Fred T. Kraus 
Martin E. Liebling 
Charles W. Markham 
Miles C. Whitener 
CLASS OF 1956 
Robert H. Duem ler 
Harriet S. Kaplan 
John S. Meyer 
Ethelee R. Smith 
CLASS OF 1957 
Zachary A. Apfel 
Carlton M. Dean, Jr. 
j: 	 Paul L. Friedman 







Ma rch 7-May 23 
Apri I 11-12 
Apri I 21-22 








Robert C. Meredith CLASS OF 1961 CLASS OF 1965 Penelope Shackelford 
Lawrence C. Paku la George E. Dueker F. Eliska Atkin s Lynn M. Taussig 
CLASS OF 1958 
Thomas C. Apostle 
Eugene F. Bartlett 
Malcolm B. Bowers, Jr. 
Ronald J. Catanzaro 
Michael Gass 
Robe rt L. Glass 
William I. Goettman 
John A. Headrick 
Dan iel F. Keller 
David M. Ke ssner 
Lucy J. King 
George A. Koehler 
Robert F. Meger 
Robert B. Winter 
James G. Hollingsworth 
Kent E. Keller 
John D. Morgan 
Gary A. Storey 
Shigemi Sugiki 
CLASS OF 1962 
Robert Edelman 
James R. Goggin 
Joel B. Kirkpatrick 
Gerald Medoff 
Laurence W. Muench 
John D. Rich 
John E. Rittmann 
Timothy W. Stevens 
David L. Dunner 
Thomas F. Frist, Jr. 
Alan S. Hendin 
Warren B. Howe 
Carl G. Kardinal 
Barry B. Kirschbaum 
Albert H. Krause 
Robert B. Telfer 
CLASS OF 1966 
Markham J. Fischer 
Gilbert J. Gordon 
H. Michael Jones 
Jerome H. Kaplan 
Daniel J. Leary, Jr. 
David L. Polage 
CLASS OF 1969 
Thomas R. Bates 
John C. Long 
Thomas B. Hall, III. 
Edward L. Knute son 
Robert C. Kolodny 
Barry A. Siegel 
CLASS OF 1970 
Eugene L. Crews 
Joanna L. Data 
James M. Mick 
Alexander L. Miller 
Lyle D. Pahnke 
Peter J. Stern 
CLASS OF 1959 
Murray H. Helfant 
Hugh F. Keister 
F. Calvin Lemon 
Irving M. Stillman 
CLASS OF 1960 
Mark Abramowicz 
Robert E. Fechner 
Edgar G. Givhan 
William B. Grubb, Jr. 
George P. Hoech, Jr. 
Donald C. Sauer 
John S. Schoentag 
Hillel Tobias 
CLASS OF 1963 
Stanford K. Au 
Ronald W. Barnet 
Gary M. Boelling 
John P. Christy 
Donald W. Humphreys 
Robert S. Hunt 
David L. Nelson 
Lawrence M. Unger 
Eugene J. Valentini 
CLASS OF 1964 
G. Arthur Carder 
Max L. Elliott 
Ann B. Fletcher 
Raymond Fletcher 
Carl F. Ritter 
Walter D. Stevenson, III. 
Leslie A. Torgerson 
CLASS OF 1967 
Milton S. Bleiweiss 
Allan C. Campbell 
Gary S. Rachelefsky 
Robert D. Shay 
Michael R. Trei ster 
Ronald H. Ullman 
Frank Vin icor 
Andreas M. Walchner 
CLASS OF 1968 
Hunter Heath, III. 
Susan G. Odom 
CLASS OF 1971 
Oren M. Conway 
David L. Diedrichsen 
Jane B. Diedrichsen 
CLASS OF 1972 
Thomas C. Hill 
CLASS OF 1973 
Edward H. Birkenmeier, III. 
Edward W. Knowlton 
CLASS OF 1974 
Peter GI ickman 
Jon F. Moran 
Alan J. Tiefenbrunn 
Phillip E. Winter 
R. Dean Wochner 
Gabriel S. Zatlin 
David L. Mcilwain 
John E. Munzen rider 
Robert G. Scheibe 
Seymour Packman 
Maribeth P. Sayre 
Gary D. Shackelford 
CLASS OF 1975 
Jo-Ellyn M. Ryall 
John W. Ze l ler 
Continuing Medical Education Calendar 

PROGRAM CHAIRMAN 
Internal Medicine Board Examination Review 
· ... Russell Eggebrecht, M.D. 
Richard Ratzen, M.D. 
4th Annual Symposium on Obstetrics & Gynecology 
. . . . . . .. . George Wulff, M.D. 
The Borderline Child 
.. Doris Gilpin, M.D. 
Eye Residents Seminar .. ....... . ........... Robert Feibel, M.D. 
An Approach to the Patient With Diarrhea ... . . .. . 
. . Gary Zuckerman, D.O. 
Jewish Hospital Medical & Surgical Program 
. Jerry Meyers, M. D. 
Washington U. Med. Center Alumni Reunion 
. .. Robert Karsh, M.D. 
Edward Lansche, M.D. 
Robert Packman, M.D. 
Edward Reinhard, M.D . 
Surgical Problems in Chi Idren . . . .. ' " . . .... Martin Bell, M.D. 
Neuromuscular Diseases · . . . Michael Brooke, M.D. 
Current Topics in Hypertension & Its Management · .. . H. Mitchell Perry, Jr., M.D. 
Perinatal Medicine . . ... Richard Marshall, M.D. 
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Vice Chancellor Comments: 
"To be worthy to serve the sufferi ng" 
is the motto of Alpha Omega Alpha, the 
medical honor society. The motto ex­
presses beautifully the high ideals of 
our profession. It recogni zes that it is 
a privilege to be a physician-a privi­
lege, much sought after and widely 
respected , that must be justified 
throughout one's professiona I life. 
Physicians justify their privilege s by 
adhering to a code of honor that governs 
their dealings with the sick and injured 
and with on e an other. No profe ss ion 
ca n hope to enjoy society's trust with­
out such a code that truly guides and 
and fortifies its practitioners. 
At different times and in various 
places, such codes for physician s have 
been expressed differently, but they al­
ways demand commitment-through 
se lf-disc ipline, hard work, and personal 
sacrifice-to med ic ine's high ideal of 
devotion to the suffering. Further, phy­
sicians are expected never to forget 
their debt to soci ety for having edu­
cated and tra ined them and their debt 
to patients who allowed. them to par­
ti c ipate in their ca re and so learn to 
be physic ians. Honor obligates us to 
acknowl edge our debts to those who1 
,\ 	 made our privileges possib le and re­
Quires us to repay in kind the sacri­I 
fices of othe rs made in our behalf. I Great professional privilege-such as 
I 	 that enjoyed by physicians-can only 
be coun tenanced when coupled to a 
demanding code of responsi bility and 
r 	 obligation to which the profession 
gladly adheres. Such codes, like our ~ 
bodies, become flabby when not sub­
jected to regular exerc ise and chal­
lenge. They are then easily compro­
mised or even dismissed cyn ica lIy when 
confronted by economic, soc ial, and 
political "realities." But we must never 
misunderstand: our priv ileges are in­
separably linked to our obligations. If 
the latter become "unrealistic" or "out­
moded," the former will surely disap­
pear. 
Samuel B . Guze, M.D. 

Vice Chancellor for Medical Affairs 


